EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Association of extracorporeal therapy with persistent neurologic sequelae after lithium poisoning: A multicentre cohort study

Amir Shabaka, Eugenia Landaluce‐Triska, Maria José Ortega Fernández‐Reyes, Miguel Martínez‐Belotto, Mario Botella, Ana Mendoza‐Cedeño, Verónica Rubio Menéndez, Javier Vian, Clara Cases‐Corona, Fabio Procaccini, Maria Jose Alcaide‐Martin, Maria Patricia Sanz‐de Pedro, Rubén Gómez Rioja, Juan Manuel Acedo, Begoña Rivas, Cristina Vega, Gema Fernández‐Juárez

British Journal of Clinical Pharmacology · 2026-10-08

DOI: 10.1002/bcp.70864 ↗
AbstractBibliografische Angaben

Abstract

Aims Lithium poisoning may result in persistent neurologic sequelae, including irreversible neurotoxicity. Although extracorporeal therapy enhances lithium elimination, its effect on clinically meaningful outcomes remains uncertain. We evaluated the association between extracorporeal therapy and persistent neurologic sequelae in patients with lithium poisoning. Methods We conducted a multicentre retrospective cohort study including 268 patients with lithium poisoning from four tertiary hospitals in Spain. The primary outcome was persistent neurologic sequelae for ≥2 months. Secondary outcomes included mortality, hospital length of stay and treatment‐related complications. Multivariable logistic regression and propensity score weighting were used to adjust for differences in baseline severity and treatment indication. Results Among 268 patients, 108 (40.3%) received extracorporeal therapy. Patients receiving extracorporeal therapy had more severe poisoning, with higher peak lithium concentrations and more frequent acute kidney injury and neurologic manifestations. Persistent neurologic sequelae occurred in 55 patients (20.5%) and were less frequent among patients treated with extracorporeal therapy (11.1% vs . 26.9%; p = 0.002). In multivariable analysis, extracorporeal therapy was independently associated with lower odds of persistent neurologic sequelae (adjusted odds ratio 0.20, 95% CI 0.09–0.45). Higher peak lithium concentration and pre‐existing neurologic disease were independently associated with persistent neurologic sequelae. Findings remained consistent after propensity score weighting. The association was strongest among patients meeting EXtracorporeal TReatments In Poisoning (EXTRIP)‐recommended criteria. Conclusions Extracorporeal therapy was associated with a lower frequency of persistent neurologic sequelae in lithium poisoning, particularly among patients meeting EXTRIP Workgroup ‘recommended’ criteria. Prospective studies are needed to confirm these findings, particularly in intermediate‐risk poisoning.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →